# Copt Defense Properties: financial statements, quarterly

CDP · NYSE · CIK 860546 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdp.md) · [Financials](/companies/cdp/financials.md) · [Filings](/companies/cdp/filings.md) · [Insiders](/companies/cdp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cdp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.9](/filings/0000860546-24-000062.md) | [18.2 d](/filings/0000860546-26-000011.md) | [26.6](/filings/0000860546-25-000026.md) | [20.3](/filings/0000860546-25-000038.md) | [16.7](/filings/0000860546-25-000048.md) | [12.0 d](/filings/0000860546-26-000011.md) | [10.3](/filings/0000860546-26-000029.md) | [12.5](/filings/0000860546-26-000040.md) | [8.5](/filings/0000860546-25-000048.md) | [10.9 d](/filings/0000860546-26-000011.md) | [6.0](/filings/0000860546-26-000029.md) | [6.8](/filings/0000860546-26-000040.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [10.6](/filings/0000860546-24-000062.md) | [11.3 d](/filings/0000860546-26-000011.md) | [11.7](/filings/0000860546-25-000026.md) | [12.0](/filings/0000860546-25-000038.md) | [11.4](/filings/0000860546-25-000048.md) | [11.8 d](/filings/0000860546-26-000011.md) | [12.2](/filings/0000860546-26-000029.md) | [11.9](/filings/0000860546-26-000040.md) | [12.0](/filings/0000860546-25-000048.md) | [11.7 d](/filings/0000860546-26-000011.md) | [12.6](/filings/0000860546-26-000029.md) | [13.3](/filings/0000860546-26-000040.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [17.8](/filings/0000860546-23-000048.md) | [20.4 d](/filings/0000860546-24-000013.md) | [20.8](/filings/0000860546-24-000039.md) | [20.6](/filings/0000860546-25-000038.md) | [20.4](/filings/0000860546-25-000048.md) | [20.4 d](/filings/0000860546-26-000011.md) | [20.5](/filings/0000860546-26-000029.md) | [20.9](/filings/0000860546-26-000040.md) | [20.9](/filings/0000860546-25-000048.md) | [24.3 d](/filings/0000860546-26-000011.md) | [24.0](/filings/0000860546-26-000029.md) | [24.4](/filings/0000860546-26-000040.md) |
| Income tax | $m | [0.2](/filings/0000860546-24-000062.md) | [0.1 d](/filings/0000860546-26-000011.md) | [0.2](/filings/0000860546-25-000026.md) | [0.0](/filings/0000860546-25-000038.md) | [0.1](/filings/0000860546-25-000048.md) | [(0.0) d](/filings/0000860546-26-000011.md) | [0.1](/filings/0000860546-26-000029.md) | [0.1](/filings/0000860546-26-000040.md) | [0.6](/filings/0000860546-25-000048.md) | [0.1 d](/filings/0000860546-26-000011.md) | [0.1](/filings/0000860546-26-000029.md) | [0.0](/filings/0000860546-26-000040.md) |
| Net income | $m | [(221)](/filings/0000860546-24-000062.md) | [34.8 d](/filings/0000860546-26-000011.md) | [33.7](/filings/0000860546-25-000026.md) | [36.4](/filings/0000860546-25-000038.md) | [37.4](/filings/0000860546-25-000048.md) | [36.5 d](/filings/0000860546-26-000011.md) | [36.2](/filings/0000860546-26-000029.md) | [40.2](/filings/0000860546-26-000040.md) | [43.7](/filings/0000860546-25-000048.md) | [39.4 d](/filings/0000860546-26-000011.md) | [40.1](/filings/0000860546-26-000029.md) | [48.6](/filings/0000860546-26-000040.md) |
| Diluted EPS | $ per share | [(1.94)](/filings/0000860546-24-000062.md) | not reported | [0.29](/filings/0000860546-25-000026.md) | [0.31](/filings/0000860546-25-000038.md) | [0.32](/filings/0000860546-25-000048.md) | not reported | [0.31](/filings/0000860546-26-000029.md) | [0.34](/filings/0000860546-26-000040.md) | [0.37](/filings/0000860546-25-000048.md) | not reported | [0.34](/filings/0000860546-26-000029.md) | [0.40](/filings/0000860546-26-000040.md) |
| Basic EPS | $ per share | [(1.94)](/filings/0000860546-24-000062.md) | not reported | [0.29](/filings/0000860546-25-000026.md) | [0.31](/filings/0000860546-25-000038.md) | [0.32](/filings/0000860546-25-000048.md) | not reported | [0.31](/filings/0000860546-26-000029.md) | [0.34](/filings/0000860546-26-000040.md) | [0.37](/filings/0000860546-25-000048.md) | not reported | [0.34](/filings/0000860546-26-000029.md) | [0.41](/filings/0000860546-26-000040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [204](/filings/0000860546-24-000062.md) | [168](/filings/0000860546-26-000011.md) | [123](/filings/0000860546-25-000026.md) | [100](/filings/0000860546-25-000038.md) | [34.5](/filings/0000860546-25-000048.md) | [38.3](/filings/0000860546-26-000040.md) | [24.3](/filings/0000860546-26-000029.md) | [21.3](/filings/0000860546-26-000040.md) | [23.7](/filings/0000860546-25-000048.md) | [275](/filings/0000860546-26-000040.md) | [28.6](/filings/0000860546-26-000029.md) | [24.2](/filings/0000860546-26-000040.md) |
| Total assets | $m | [4,239](/filings/0000860546-24-000062.md) | [4,247](/filings/0000860546-25-000008.md) | [4,233](/filings/0000860546-25-000026.md) | [4,219](/filings/0000860546-25-000038.md) | [4,234](/filings/0000860546-25-000048.md) | [4,254](/filings/0000860546-26-000011.md) | [4,250](/filings/0000860546-26-000029.md) | [4,287](/filings/0000860546-26-000040.md) | [4,351](/filings/0000860546-25-000048.md) | [4,702](/filings/0000860546-26-000040.md) | [4,459](/filings/0000860546-26-000029.md) | [4,515](/filings/0000860546-26-000040.md) |
| Total liabilities | $m | [2,692](/filings/0000860546-23-000048.md) | [2,700](/filings/0000860546-25-000008.md) | [2,684](/filings/0000860546-24-000039.md) | [2,666](/filings/0000860546-24-000054.md) | [2,679](/filings/0000860546-24-000062.md) | [2,694](/filings/0000860546-26-000011.md) | [2,688](/filings/0000860546-25-000026.md) | [2,718](/filings/0000860546-25-000038.md) | [2,772](/filings/0000860546-25-000048.md) | [3,114](/filings/0000860546-26-000040.md) | [2,867](/filings/0000860546-26-000029.md) | [2,909](/filings/0000860546-26-000040.md) |
| Long-term debt | $m | [2,416](/filings/0000860546-23-000048.md) | [2,416](/filings/0000860546-25-000008.md) | [2,417](/filings/0000860546-24-000039.md) | [2,390](/filings/0000860546-24-000054.md) | [2,391](/filings/0000860546-24-000062.md) | [2,392](/filings/0000860546-26-000011.md) | [2,413](/filings/0000860546-25-000026.md) | [2,439](/filings/0000860546-25-000038.md) | [2,444](/filings/0000860546-25-000048.md) | [2,768](/filings/0000860546-26-000040.md) | [2,547](/filings/0000860546-26-000029.md) | [2,592](/filings/0000860546-26-000040.md) |
| Shareholders' equity | $m | [1,486](/filings/0000860546-23-000048.md) | [1,484](/filings/0000860546-25-000008.md) | [1,482](/filings/0000860546-24-000039.md) | [1,487](/filings/0000860546-24-000054.md) | [1,489](/filings/0000860546-24-000062.md) | [1,493](/filings/0000860546-26-000011.md) | [1,491](/filings/0000860546-25-000026.md) | [1,498](/filings/0000860546-25-000038.md) | [1,507](/filings/0000860546-25-000048.md) | [1,515](/filings/0000860546-26-000040.md) | [1,515](/filings/0000860546-26-000029.md) | [1,528](/filings/0000860546-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [68.7 d](/filings/0000860546-24-000062.md) | [66.6 d](/filings/0000860546-26-000011.md) | [71.0](/filings/0000860546-25-000026.md) | [93.8 d](/filings/0000860546-25-000038.md) | [65.1 d](/filings/0000860546-25-000048.md) | [101 d](/filings/0000860546-26-000011.md) | [72.1](/filings/0000860546-26-000029.md) | [87.9 d](/filings/0000860546-26-000040.md) | [68.6 d](/filings/0000860546-25-000048.md) | [81.3 d](/filings/0000860546-26-000011.md) | [96.4](/filings/0000860546-26-000029.md) | [91.1 d](/filings/0000860546-26-000040.md) |
| Dividends paid | $m | [32.1 d](/filings/0000860546-24-000062.md) | [32.1 d](/filings/0000860546-26-000011.md) | [32.1](/filings/0000860546-25-000026.md) | [33.2 d](/filings/0000860546-25-000038.md) | [33.2 d](/filings/0000860546-25-000048.md) | [33.3 d](/filings/0000860546-26-000011.md) | [33.3](/filings/0000860546-26-000029.md) | [34.4 d](/filings/0000860546-26-000040.md) | [34.4 d](/filings/0000860546-25-000048.md) | [34.4 d](/filings/0000860546-26-000011.md) | [34.6](/filings/0000860546-26-000029.md) | [36.3 d](/filings/0000860546-26-000040.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [113](/filings/0000860546-23-000048.md) | [113](/filings/0000860546-24-000039.md) | [113](/filings/0000860546-24-000054.md) | [112](/filings/0000860546-24-000062.md) | [113](/filings/0000860546-25-000026.md) | [113](/filings/0000860546-25-000038.md) | [113](/filings/0000860546-25-000048.md) | [113](/filings/0000860546-26-000029.md) | [113](/filings/0000860546-26-000040.md) | [113](/filings/0000860546-25-000048.md) | [114](/filings/0000860546-26-000029.md) | [115](/filings/0000860546-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 113,410,458 at 2026-07-20, from the cover of the [10-Q filed 2026-08-03](/filings/0000860546-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.